Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
  • Most recent
    • Best match

News

The Lancet4d
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Copyright: © 2016 Elsevier Ltd. All rights reserved.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Air India plane crashes
To leave DNC post
Judge blocks deportation
Convicted of sexual assault
Judge denies Newsom’s plea
Inflation rose to 2.4% in May
Evacuation orders lifted
To deploy National Guard
Accused of bribing WI voters
ICE raids Omaha meat plant
US Navy sailor found dead
Beach Boys co-founder dies
Former MTV VJ dies at 52
Denmark approves US bases
Female athletes file appeal
Possible sighting of Decker
Ex-NBA star suspended
‘Scarface’ actor dies
US to review AUKUS pact
Ex-CIA analyst sentenced
Kosovo to accept migrants
1st view of Sun's south pole
‘General Hospital' actor dies
NJ man gored by bison
To attend 'Les Misérables'
Vetoes antisemitism bill
New species discovered
Silentó sentenced to 30 years
Offers buyouts to staff
Fulbright board resigns
Silver Airways shuts down
To address Israeli Knesset
South Africa floods
Senate confirmation hearing
Sue AI image firm Midjourney
NYC crypto kidnapping case
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy